Dumontet, Charles
Hulin, Cyrille
Dimopoulos, Meletios A.
Belch, Andrew
Dispenzieri, Angela
Ludwig, Heinz
Rodon, Philippe
Van Droogenbroeck, Jan
Qiu, Lugui
Cavo, Michele
Van de Velde, Ann
Lahuerta, Juan José
Allangba, Olivier
Lee, Jae Hoon
Boyle, Eileen
Perrot, Aurore
Moreau, Philippe
Manier, Salomon
Attal, Michel
Roussel, Murielle
Mohty, Mohamad
Mary, Jean Yves
Civet, Alexandre
Costa, Bruno
Tinel, Antoine
Gaston-Mathé, Yann
Facon, Thierry
Article History
Received: 13 March 2018
Accepted: 19 March 2018
First Online: 26 April 2018
Compliance with ethical standards
:
: Charles Dumontet has received honoraria from Sanofi and Janssen, has received fees for a consulting/advisory role from Merck, and has received research funding from Roche. Cyrille Hulin has received honoraria from Celgene, Amgen, Bristol-Myers Squibb, Novartis, Janssen-Cilag, and Takeda. Meletios A. Dimopoulos has received honoraria from Amgen, Celgene, Janssen, and Takeda and has received fees for a consulting/advisory role from Amgen, Celgene, Janssen, and Takeda. Angela Dispenzieri has received research funding from Alnylam, Celgene, Pfizer, Prothena, and Takeda. Heinz Ludwig has received speakers’ bureau fees from Celgene, Janssen, Takeda, and Amgen and has received research funding from Takeda and Amgen. Michele Cavo has received honoraria from Amgen, Bristol-Myers Squibb, Celgene, Janssen, and Takeda. Juan José Lahuerta has received fees for a consulting/advisory role from Celgene, Janssen, and Takeda. Olivier Allangba has received fees for a consulting/advisory role from Novartis and has received travel, accommodations, and expenses from Takeda, Pfizer, Celgene, Amgen, and Roche. Eileen Boyle has received fees for a consulting/advisory role from Celgene. Aurore Perrot has received honoraria and fees for a consulting/advisory role from Celgene, Janssen, Takeda, and Bristol-Myers Squibb. Philippe Moreau has received honoraria from Celgene, Takeda, Novartis, Amgen, and Janssen-Cilag and has received fees for a consulting/advisory role from Celgene, Takeda, Novartis, Amgen, and Janssen. Murielle Roussel has received research funding from Amgen, Celgene, and Janssen. Mohamad Mohty has received honoraria from Celgene, Janssen, Bristol-Myers Squibb, Takeda, Novartis, and Amgen; fees for consulting/advisory role from Celgene, Janssen, Bristol-Myers Squibb, Takeda, Novartis, and Amgen; speakers’ bureau fees from Janssen and Sanofi; research funding from Sanofi; and travel, accommodations, expenses from Sanofi, JAZZ, Novartis, Janssen, and Amgen. Alexandre Civet has received fees for a consulting/advisory role from Celgene. Bruno Costa is an employee of and owns stock in Celgene. Antoine Tinel is an employee of and owns stock in Celgene. Yann Gaston-Mathé is an employee of IntegraGen, has received fees for a consulting/advisory role from Celgene, and has received travel, accommodations, expenses from Celgene. Thierry Facon has received fees for a consulting/advisory role from Amgen, Celgene, Janssen, Karyopharm, PharmaMar, and Takeda and has received speakers’ bureau fees from Amgen, Celgene, Janssen, and Takeda. Andrew Belch, Philippe Rodon, Jan Van Droogenbroeck, Lugui Qiu, Ann Van de Velde, Jae Hoon Lee, Salomon Manier, Michel Attal, and Jean Yves Mary declare that they have no conflict of interest.